A stepwise approach to management of stable COPD with inhaled pharmacotherapy: A review

Ruben D. Restrepo

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.

    Original languageEnglish (US)
    Pages (from-to)1058-1081
    Number of pages24
    JournalRespiratory Care
    Volume54
    Issue number8
    StatePublished - Aug 2009

    Fingerprint

    Chronic Obstructive Pulmonary Disease
    Drug Therapy
    Guidelines
    Nebulizers and Vaporizers
    Health Personnel
    Lung
    Therapeutics

    Keywords

    • β adrenergics
    • Anticholinergics
    • Chronic obstructive pulmonary disease
    • COPD
    • Global Initiative for Chronic Obstructive Lung Disease
    • GOLD
    • Guidelines
    • Inhalation pharmacotherapy

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine
    • Critical Care and Intensive Care Medicine

    Cite this

    A stepwise approach to management of stable COPD with inhaled pharmacotherapy : A review. / Restrepo, Ruben D.

    In: Respiratory Care, Vol. 54, No. 8, 08.2009, p. 1058-1081.

    Research output: Contribution to journalArticle

    @article{4c2d934e95f54593baded56a05851d69,
    title = "A stepwise approach to management of stable COPD with inhaled pharmacotherapy: A review",
    abstract = "Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.",
    keywords = "β adrenergics, Anticholinergics, Chronic obstructive pulmonary disease, COPD, Global Initiative for Chronic Obstructive Lung Disease, GOLD, Guidelines, Inhalation pharmacotherapy",
    author = "Restrepo, {Ruben D.}",
    year = "2009",
    month = "8",
    language = "English (US)",
    volume = "54",
    pages = "1058--1081",
    journal = "Respiratory Care",
    issn = "0020-1324",
    publisher = "Daedalus Enterprises Inc.",
    number = "8",

    }

    TY - JOUR

    T1 - A stepwise approach to management of stable COPD with inhaled pharmacotherapy

    T2 - A review

    AU - Restrepo, Ruben D.

    PY - 2009/8

    Y1 - 2009/8

    N2 - Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.

    AB - Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.

    KW - β adrenergics

    KW - Anticholinergics

    KW - Chronic obstructive pulmonary disease

    KW - COPD

    KW - Global Initiative for Chronic Obstructive Lung Disease

    KW - GOLD

    KW - Guidelines

    KW - Inhalation pharmacotherapy

    UR - http://www.scopus.com/inward/record.url?scp=68549086902&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=68549086902&partnerID=8YFLogxK

    M3 - Article

    C2 - 19650947

    AN - SCOPUS:68549086902

    VL - 54

    SP - 1058

    EP - 1081

    JO - Respiratory Care

    JF - Respiratory Care

    SN - 0020-1324

    IS - 8

    ER -